All India Institute of Medical Sciences, New Delhi, India.
Curr Opin Pediatr. 2010 Apr;22(2):189-96. doi: 10.1097/MOP.0b013e32833683fd.
Transplantation is the preferred method of treatment for end-stage renal disease in children. The rate of pediatric kidney transplantation has been steadily rising over the past decade. The use of increasingly potent immunosuppressive drugs has lessened the risk for acute rejection substantially and improved short-term outcomes; however, the long-term outcomes have remained inadequate.
The follow-up of pediatric cohorts and the encouraging results from data registries prompt us to revisit our practices in transplantation so as to devise additional strategies to improve long-term outcomes.
This review presents a comprehensive discussion of the major issues in pediatric renal transplantation, the newer immunosuppression approaches to limit toxicities of therapies in children and some critical issues that remain to be addressed, specific to the care of the transplanted child. The ultimate goal of designing optimum conditions for equating graft survival to patient survival still remains a major goal for pediatric organ transplantation.
移植是儿童终末期肾病的首选治疗方法。在过去的十年中,儿童肾移植的比例稳步上升。越来越有效的免疫抑制剂的使用大大降低了急性排斥反应的风险,并改善了短期结果;然而,长期结果仍然不够理想。
对儿科队列的随访以及数据登记处令人鼓舞的结果促使我们重新审视我们在移植方面的实践,以便制定额外的策略来改善长期结果。
本综述全面讨论了儿童肾移植的主要问题、限制儿童治疗毒性的新免疫抑制方法以及一些仍有待解决的关键问题,这些问题是特定于移植儿童的护理。为使移植物存活率与患者存活率相匹配而设计最佳条件的最终目标仍然是儿科器官移植的主要目标。